Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding

Journal of Thrombosis and Thrombolysis

Volumn 36, Issue 1, 2013, Pages 102-108

  Imberti, D ^a,e   Magnacavallo, A ^a   Dentali, F ^b   Condoleo, E ^a   Gallerani, M ^c   Benedetti, R ^d   Ageno, W ^b  

^a Ospedale Civile   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^d Ospedale Civile   (Italy)

^e Piacenza Hospital   (Italy)

Author keywords

Major bleeding; Prothrombin complex concentrates; Vitamin K antagonists

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 9; PROTHROMBIN; PROTHROMBIN COMPLEX; UMAN COMPLEX; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTINUOUS INFUSION; DRUG ANTAGONISM; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; EMERGENCY TREATMENT; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENDER; HEMATOTHORAX; HEMOPERITONEUM; HEMOPTYSIS; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; VITAMIN K;

EID: 84879230652     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0817-4     Document Type: Article

References (43)

1. Ageno W, Gallus AS, Wittkowsky A et al (2012) Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th Edition). Chest 141:e44S-e88S
2. Palareti G, Leali N, Coccheri S et al (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative trial (ISCOAT). Lancet 348:423-428
3. Ageno W, Garcia D, Aguilar MI et al (2009) Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: treatment. Am J Hematol 84:584-588
4. Nicolini A, Ghirarduzzi A, Iorio A et al (2002) Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia. Haematologica 87:948-956
5. Baldi G, Altomonte F, Altomonte M et al (2006) Intracranial haemorrhage in patients on antithrombotics: clinical presentation and determinants of outcome in a prospective multicentric study in Italian emergency departments. Cerebrovasc Dis 22:286-293
6. Garcia DA, Regan S, Crowther M, Hylek EM (2006) The risk of hemorrhage among patients with warfarin-associated coagulopathy. J Am Coll Cardiol 47:804-808
7. Go AS, Hylek EM, Chang Y et al (2003) Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290:2685-2692
8. Rosand J, Eckman MH, Knudsen KA et al (2004) The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164:880-884
9. Aguilar MI, Hart RG, Kase CS et al (2007) Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 82:82-92
10. Makris M, Greaves M, Phillips W et al (1997) Emergency oral anticoagulant reversal: the relative efficacy of infusion of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 77:477-480
11. Boulis NM, Bobek MP, Schmaier A, Hoff JT (1999) Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 45:1113-1118
12. Yasaka M, Sakata T, Minematsu K, Naritomi H (2002) Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complications. Thromb Res 108:25-30
13. Riess HB, Meier-Hellmann A, Motsch J et al (2007) Prothrombin complex concentrate (octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res 121:9-16
14. Lorenz R, Kienast J, Otto U et al (2007) Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study. Blood Coagul Fibrinolysis 18:565-570
15. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B (2008) Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 83:137-143
16. Marietta M, Pedrazzi P, Girardis M, Torelli G (2007) Intracerebral haemorrage: an often neglected medical emergency. Intern Emerg Med 2:38-45
17. Yasaka M, Sakata T, Naritomi H, Minematsu K (2005) Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res 115:455-459
18. Fredriksson K, Norrving B, Stromblad LG (1992) Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 23:972-977
19. Cartmill M, Dolan G, Byrne JL, Byrne PO (2000) Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 14:458-461
20. Huttner HB, Schellinger PD, Hartmann M et al (2006) Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 37:1465-1470
21. Guidelines of the FCSA (2003) A guide to oral anticoagulant treatment. Haematologica 88(suppl.2): 1-47
22. Baglin TP, Keeling DM, Watson HG (2006) Guidelines on oral anticoagulation (warfarin): third edition - 2005 update. Br J Haematol 132:277-285
23. Steiner T, Kaste M, Forsting M et al (2006) Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 22:294-316
24. Freilone R, Polio B, Delios G et al (2009) Efficacy and safety of prothrombin complex concentrate (Uman complex) and vitamin K in a cohort of 56 patients with anticoagulation-related acute intracranial haemorrhage: clinical features and outcomes at three months. Haematologica 94(s4):114-115
25. Tiraferri E, Galletti M, Argento A (2004) Emergency use of prothrombin complex concentrates in oral anticoagulant therapy. Rapid reversal. Haematologica 89:177
26. Van Aart L, Eijkhout HW, Kamphuis JS et al (2007) Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. Thromb Res 119:15-16
27. Imberti D, Barillari G, Biasioli C et al (2009) Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage. Pathophysiol Haemost Thromb 36:259-265
28. Evans G, Luddington R, Baglin T (2001) Beriplex P/N reverses severe warfarin induced overcoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol 115:998-1001
29. Preston FE, Laidlaw ST, Sampson B, Kitchen S (2002) Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 116:619-624
30. Lankiewicz MW, Hays J, Friedman KD et al (2006) Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 4:967-970
31. Pabinger I, Brenner B, Kalina U et al (2008) Beriplex P/N anticoagulation reversal study group. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost 6:622-631
32. Viguè M, Ract C, Tremey B et al (2007) Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial haemorrhage. Intensive Care Med 33:721-725
33. Imberti D, Barillari G, Biasioli C et al (2011) Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrates in patients with intracranial haemorrhage. Blood Transfus 9:148-155
34. Dentali F, Marchesi C, Pierfranceschi MG et al (2011) Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 106(3):429-438
35. Kessler CM (2006) Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-base data? J Thromb Haemost 4:963-966
36. Holland L, Warkentin TE, Refaai M et al (2009) Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion 49:1171-1177
37. Sorensen B, Johansen P, Nielsen GL et al (2003) Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 14:469-477
38. Freeman WD, Brott TG, Barrett KM et al (2004) Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 7:1495-1500
39. Brody DL, Aiyagari V, Shackeford AM, Diringer MN (2005) Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care 2:263-267
40. Dickneite G (2007) Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation. Thromb Res 119:643-651
41. Tanaka KA, Szlam F, Dickneite G, Levy JH (2008) Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thromb Res 122:117-123
42. Sørensen B, Spahn DR, Innerhofer P et al (2011) Clinical review: prothrombin complex concentrates-evaluation of safety and thrombogenicity. Crit Care 15(2):409
43. Franchini M, Lippi G (2010) Prothrombin complex concentrates: an update. Blood Transfus 8:149-154